1) RS won't crush the stock. Bankruptcy will. Get it right.
2) There won't be a lawsuit because it will go bankrupt earlier.
3) Just one "c" in "bankruptcy".
The FDA is probably the most efficient agency in the government.
The management is incompetent. I don't understand how people hope that FDA news will save this company.
Oh well.... someone kept selling it off by 3-5 cents as soon as it hit $4.20 for hours and probably covered at 3:00PM. Happy Thanksgiving everyone...
*goes into hibernation mode till Friday*
"Sientra successfully argued that this lawsuit, the 14th consecutive case brought by J&J/Mentor against either Sientra or its employees in the last 18 months..."
Replace "DOT" with ".".
toxic warrants were known before it fell 95% in late August, yet it still fell. Who cares about revenue when costs are 2x revenue and they will run out of cash? No, this has no chance.
How stupid? I am not short this P.O.S. They are going to dilute by 80%. That's what the warrants say. If you don't believe me read the filings.
I don't know what will happen in that case. That wouldn't be ideal certainly. I would like to believe that the European regulators will be able to reach a consensus with the FDA.
The CE mark was revoked on Silimed products sold in Europe. Sientra doesn't need that mark since that's only for European sales and Sientra sells in the US. They stopped selling inventory in the US for marketing reasons.
The rest of the inventory may indeed have the same microscopic particles but if they manage to get the FDA to specifically agree (again?) that they pose no risk after this current round of investigation, Sientra will be selling that inventory.
Look at the new expected authorized shares. GBSN has a -80% dilution in the cards, then bankruptcy when they are unable to finance their enormous cash burn.